News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Migami, Inc. Continues Implementation of Acquisition Strategy Regarding Various Proprietary Drug-Delivery Platforms and Manufacturing Facilities


4/3/2009 8:55:02 AM

WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Migami, Inc. (symbol: MIGA), a pharmaceutical and cosmeceutical company located in Woodland Hills, CA, (“Migami”) is negotiating a Letter of Intent (“LOI”) regarding an Asset Purchase for certain GMP manufacturing assets. The LOI being negotiated contemplates the purchase of a 90,000-square feet, state-of-the-art manufacturing facility in Arizona and other related assets.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES